| Michael A D'anca, MD | |
|
1401 Franklin Ave, Garden City, NY 11530-1613 | |
| (516) 877-2626 | |
| (516) 877-0946 |
| Full Name | Michael A D'anca |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 20 Years |
| Location | 1401 Franklin Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477878791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 254385 (New York) | Primary |
| 207R00000X | Internal Medicine | 254385 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by Pharmacy students at the University of Bath to help practise diagnostic skills and treating patients.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
According to obesity expert and University of Melbourne professor of medicine Joseph Proietto the high failure rate of weight-loss programs could be explained by growing evidence that an obese person's body is programmed to regain any weight that is lost. He said that authorities are wasting money on campaigns urging people to exercise and eat healthy food since obesity is "''physiologically defended".
› Verified 6 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by Pharmacy students at the University of Bath to help practise diagnostic skills and treating patients.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
According to obesity expert and University of Melbourne professor of medicine Joseph Proietto the high failure rate of weight-loss programs could be explained by growing evidence that an obese person's body is programmed to regain any weight that is lost. He said that authorities are wasting money on campaigns urging people to exercise and eat healthy food since obesity is "''physiologically defended".
› Verified 6 days ago
| Entity Name | Winthrop Community Medical Affiliates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by Pharmacy students at the University of Bath to help practise diagnostic skills and treating patients.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
According to obesity expert and University of Melbourne professor of medicine Joseph Proietto the high failure rate of weight-loss programs could be explained by growing evidence that an obese person's body is programmed to regain any weight that is lost. He said that authorities are wasting money on campaigns urging people to exercise and eat healthy food since obesity is "''physiologically defended".
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael A D'anca, MD 1401 Franklin Ave, Garden City, NY 11530-1613 Ph: (516) 877-2626 | Michael A D'anca, MD 1401 Franklin Ave, Garden City, NY 11530-1613 Ph: (516) 877-2626 |
News Archive
A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by Pharmacy students at the University of Bath to help practise diagnostic skills and treating patients.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
According to obesity expert and University of Melbourne professor of medicine Joseph Proietto the high failure rate of weight-loss programs could be explained by growing evidence that an obese person's body is programmed to regain any weight that is lost. He said that authorities are wasting money on campaigns urging people to exercise and eat healthy food since obesity is "''physiologically defended".
› Verified 6 days ago
Dr. Daniel S Donohue, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8650 Fax: 516-745-5476 | |
Jung H Youn, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Franklin Ave, Suite 300, Garden City, NY 11530 Phone: 516-248-6868 Fax: 516-248-6841 | |
Dr. Miguel Cima, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 28, Garden City, NY 11530 Phone: 516-222-1000 Fax: 516-222-1017 | |
Dr. Philip Stein, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 975 Stewart Ave, Garden City, NY 11530 Phone: 516-222-8630 Fax: 516-745-5476 | |
Dr. Kinga Marta Riccobono, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 Franklin Ave, Suite 106, Garden City, NY 11530 Phone: 516-240-8700 Fax: 516-240-8787 | |
Dr. Robert J Bonasera, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1205 Franklin Ave Ste 150, Garden City, NY 11530 Phone: 516-222-0067 Fax: 516-222-0071 | |
Dr. Richard Keith Schwartz, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Franklin Ave, Garden City, NY 11530 Phone: 516-877-2626 Fax: 516-877-0945 |